Article Abstract

Are the metabolic evaluation criteria sufficient for FDG PET/CT after chemo-radiotherapy in non-small cell lung cancer?

Authors: Cetin Ordu

Abstract

Although the predictive and prognostic value of metabolic imaging by positron emision tomography (PET) in diagnosis, staging, recurrence determination and early response assessment in non-small cell lung cancer (NSCLC) is known, the standard in the evaluation of response to treatment in locally advanced NSCLC is unclear (1).

Article Options

Download Citation